Digest Network Come funziona
Network
/
Società
Cl
Non verificato

Click Therapeutics, Inc.

Di cosa scriviamo

FarmaceuticaIndustriaSaluteSoftwareTecnica

5 comunicati stampa

Guarda tutti i comunicati
15/04/2025
Industria
Sanità
Software
Farmaceutica
Information Technology
Tecnica
Medicina - Varie
Biotecnologia
Igiene alimentare
Salute
Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
Fonte
Click Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/04/2025
Click Therapeutics Underscores Its Commitment to Innovation and Leadership in Software as Prescription Medical Treatments with Launch of New Brand Identity
Fonte
Click Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/10/2024
Industria
Software
Scienza
Sanità
Farmaceutica
Tecnica
Igiene alimentare
Salute
Click Therapeutics Launches Software-Enhanced Drug™ Therapies as Part of New Click SE™ Offering
Fonte
Click Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/10/2024
Mercato del lavoro
Eventi
Software
Scienza
Farmaceutica
Tecnica
Libri/Editoria
Medicina - Varie
Biotecnologia
Comunicazione
Salute
Click Therapeutics Founder and CEO David Benshoof Klein Named to 2024 PharmaVoice 100 List
Fonte
Click Therapeutics, Inc.
Emittente
Business Wire
1.00
0
04/09/2024
Scienza
Tecnica
Software
Sanità
Biotecnologia
Farmaceutica
Salute
Industria
Click Therapeutics Announces CT-132 Met Primary Endpoint for the Reduction of Monthly Migraine Days in ReMMi-D Pivotal Trial
Fonte
Click Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0